NCT04020172View on ClinicalTrials.gov

Improving Tissue Oxygenation in Breast Reconstruction Surgery

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 12, 2019

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions
Perioperative Tissue Oxygenation
Interventions
DRUG

Dobutamine

intraoperative fluid administration will be guided by cardiac output monitoring

Trial Locations (2)

K7L2V7

Kingston General Hospital, Kingston

Unknown

Hotel Dieu Hospital, Kingston

All Listed Sponsors
lead

Dr. Glenio Mizubuti (MD, PhD)

OTHER

NCT04020172 - Improving Tissue Oxygenation in Breast Reconstruction Surgery | Biotech Hunter | Biotech Hunter